Qiagen N.V. | Balance Sheet

Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
383
627
303
538
1,048
1,419
Total Accounts Receivable
334
310
450
328
402
398
Inventories
128
132
137
137
156
163
Other Current Assets
76
26
72
36
42
175
Total Current Assets
921
1,095
962
1,038
1,648
2,155
Net Property, Plant & Equipment
445
384
443
437
494
512
Total Investments and Advances
-
194
187
56
58
370
Intangible Assets
2,646
2,714
2,512
2,483
2,512
2,584
Other Assets
71
52
84
227
287
85
Total Assets
4,088
4,606
4,190
4,308
5,039
5,748
ST Debt & Current Portion LT Debt
5
132
1
5
10
Accounts Payable
51
46
52
51
59
Income Tax Payable
41
29
24
27
21
Other Current Liabilities
241
224
191
225
234
Total Current Liabilities
337
430
268
308
325
Long-Term Debt
845
1,144
1,060
1,073
1,761
Provision for Risks & Charges
-
-
-
11
12
Deferred Taxes
139
57
74
28
37
Other Liabilities
38
214
224
269
322
Total Liabilities
1,365
2,013
1,628
1,701
2,498
Common Equity (Total)
2,714
2,584
2,560
2,607
2,541
Total Shareholders' Equity
2,714
2,584
2,560
2,607
2,541
Total Equity
2,724
2,593
2,562
2,607
2,541
Liabilities & Shareholders' Equity
4,088
4,606
4,190
4,308
5,039
Accumulated Minority Interest
10
8
2
-
-

About Qiagen

View Profile
Address
Hulsterweg 82
Venlo Limburg 5912 PL
Netherlands
Employees -
Website http://www.qiagen.com
Updated 07/08/2019
QIAGEN NV is a holding company, which engages in the manufacture and distribution of sample and assay technology products for preanalytical sample preparations. It provides solutions to customers that are classified into molecular diagnostics, applied testing, pharma, and academia. Its products include instruments, and consumables and related products.